SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Stephen who wrote (5828)10/7/1998 9:18:00 AM
From: BigKNY3  Read Replies (3) | Respond to of 9523
 
JP Morgan Recommending PFE

CNBC reports this am that JP Morgan is strongly recommending PFE and recommending a switch out of SGP and LLY. "Selling is overdone." Stay tune!

A Return to PFun Today?

BigKNY3



To: Stephen who wrote (5828)10/7/1998 10:38:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Pfizer Inc. Raised to 'Buy' at Dresdner Kleinwort Benson

Bloomberg News
October 7, 1998, 9:48 a.m. ET

Princeton, New Jersey, Oct. 7 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was raised to ''buy'' from ''add'' by analyst Premal Pajwani at Dresdner
Kleinwort Benson Securities Ltd. The 12-month target price is $125.00 per
share.

-- Sybil Carlson in Princeton, New Jersey, (609)279-3615